Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasmRecruitingNot stated2026-08-26NCT06902545

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Astellas Pharma Korea, Inc.3

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
KR82001SeoulSouth Korea1
KR82002SeoulSouth Korea1
KR82003SeoulSouth Korea1
KR82004SeoulSouth Korea1
KR82005SeoulSouth Korea1
KR82006YangsanSouth Korea1
KR82007SeoulSouth Korea1
KR82008SuwonSouth Korea1
KR82009SuwonSouth Korea1
KR82010Goyang-siSouth Korea1
KR82011SeoulSouth Korea1
KR82012Hwasun GunSouth Korea1
KR82013SeoulSouth Korea1
KR82015DaejeonSouth Korea1